A nontrivial differential diagnosis in COVID-19 pandemic: a case report and literary review of amiodarone induced interstitial pneumonia
暂无分享,去创建一个
F. Crea | A. Smargiassi | L. Cappannoli | A. Telesca | R. Scacciavillani | Edoardo Petrolati | A. Rabini | M. Massetti | N. Aspromonte
[1] Derya Yakar,et al. Chest CT Imaging Signature of COVID-19 Infection: In Pursuit of the Scientific Evidence , 2020 .
[2] T. Henry,et al. The Limited Sensitivity of Chest Computed Tomography Relative to Reverse Transcription Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus-2 Infection , 2020, Investigative radiology.
[3] L. Cappannoli,et al. 2019 novel-coronavirus: Cardiovascular insights about risk factors, myocardial injury, therapy and clinical implications , 2020, Chronic Diseases and Translational Medicine.
[4] Derya Yakar,et al. Chest CT Imaging Signature of Coronavirus Disease 2019 Infection , 2020, Chest.
[5] Sanjiv Sharma,et al. CT in coronavirus disease 2019 (COVID-19): a systematic review of chest CT findings in 4410 adult patients , 2020, European Radiology.
[6] F. Crea,et al. 2019 novel coronavirus: what is currently known, cardiovascular implications and management. , 2020, Minerva cardioangiologica.
[7] D. Brodie,et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study , 2020, The Lancet.
[8] C. Roy,et al. Acute Pulmonary Embolism in COVID-19 Patients on CT Angiography and Relationship to D-Dimer Levels , 2020, Radiology.
[9] Jianfeng Zhang,et al. CT imaging features of 4121 patients with COVID‐19: A meta‐analysis , 2020, Journal of medical virology.
[10] Yutao Guo,et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up , 2020, Journal of the American College of Cardiology.
[11] Yiyan Song,et al. Stability issues of RT‐PCR testing of SARS‐CoV‐2 for hospitalized patients clinically diagnosed with COVID‐19 , 2020, Journal of medical virology.
[12] Heshui Shi,et al. Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study , 2020, Radiology.
[13] P. Zhou,et al. Histopathologic Changes and SARS–CoV-2 Immunostaining in the Lung of a Patient With COVID-19 , 2020, Annals of Internal Medicine.
[14] R. Lu,et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. , 2020, JAMA.
[15] Haibo Xu,et al. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer , 2020, Journal of Thoracic Oncology.
[16] Yicheng Fang,et al. Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR , 2020, Radiology.
[17] Jiyuan Zhang,et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.
[18] M. Bassetti,et al. The novel Chinese coronavirus (2019‐nCoV) infections: Challenges for fighting the storm , 2020, European journal of clinical investigation.
[19] T. Schneider,et al. Rapid onset of amiodarone induced pulmonary toxicity after lung lobe resection – A case report and review of recent literature , 2017, Annals of medicine and surgery.
[20] K. Nugent,et al. Acute Amiodarone Pulmonary Toxicity After Surgical Procedures , 2016, The American journal of the medical sciences.
[21] A. Sweidan,et al. Amiodarone-Induced Pulmonary Toxicity – A Frequently Missed Complication , 2016, Clinical medicine insights. Case reports.
[22] Bo Ra Kim,et al. Very Early Onset of Amiodarone-Induced Pulmonary Toxicity , 2013, Korean circulation journal.
[23] L. Polonski,et al. Amiodarone-induced pulmonary toxicity , 2012, Canadian Medical Association Journal.
[24] M. Schalij,et al. Amiodarone: an effective antiarrhythmic drug with unusual side effects , 2010, Heart.
[25] S. Papiris,et al. Amiodarone: review of pulmonary effects and toxicity. , 2010, Drug safety.
[26] H. Morita,et al. Clinical features of and effects of angiotensin system antagonists on amiodarone-induced pulmonary toxicity. , 2010, International journal of cardiology.
[27] B. Bailey,et al. Reduction of amiodarone pulmonary toxicity in patients treated with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers , 2007, Therapeutic advances in respiratory disease.
[28] M. Harada,et al. Relationship between amiodarone-induced subclinical lung toxicity and Th1/Th2 balance. , 2009, International journal of cardiology.
[29] D. Sidi,et al. Acute amiodarone-induced pulmonary toxicity: an association of risk factors in a child operated by arterial switch operation. , 2008, Congenital heart disease.
[30] J. Hughes,et al. Amiodarone-induced pulmonary toxicity. , 2008, British journal of clinical pharmacology.
[31] R. Trohman,et al. Prescribing amiodarone: an evidence-based review of clinical indications. , 2007, JAMA.
[32] P. Foucher,et al. Interstitial Lung Disease Induced by Drugs and Radiation , 2004, Respiration.
[33] L. Siddoway. Amiodarone: guidelines for use and monitoring. , 2003, American family physician.
[34] K. Bloch,et al. Acute Amiodarone-Induced Pulmonary Toxicity following Lung Resection , 2003, Respiration.
[35] V. Muse,et al. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 12-2003. An 82-year-old man with dyspnea and pulmonary abnormalities. , 2003, The New England journal of medicine.
[36] D. Narula,et al. Diagnosis of Amiodarone Pulmonary Toxicity with HighResolution Computerized Tomographic Scan , 2001, Journal of cardiovascular electrophysiology.
[37] E. Aranda. Bronchiolitis obliterans organising pneumonia secondary to amiodarone treatment. , 1998 .
[38] R. Alkiza Basañez,et al. Bronchiolitis obliterans organising pneumonia secondary to amiodarone treatment. , 1998, The Netherlands journal of medicine.
[39] S Kacew,et al. An Evaluation of Possible Mechanisms Underlying Amiodarone-Induced Pulmonary Toxicity 1 , 1996, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[40] J. Golden,et al. Hydrostatic pulmonary edema: high-resolution CT findings. , 1995, AJR. American journal of roentgenology.
[41] M. Polkey,et al. Amiodarone pneumonitis: no safe dose. , 1995, Respiratory medicine.
[42] W. Stevenson,et al. Amiodarone and Post‐MI Patients , 1993, Circulation.
[43] E. Rosenow,et al. Amiodarone pulmonary toxicity. , 2004, Clinics in chest medicine.
[44] P. Colson,et al. Postoperative Acute Respiratory Distress Syndrome: A Complication of Amiodarone Associated with 100 Percent Oxygen Ventilation , 1992 .
[45] M. Shenasa,et al. Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias. , 1989, The Canadian journal of cardiology.
[46] P. Armstrong,et al. Distribution of amiodarone and its metabolite, desethylamiodarone, in human tissues. , 1987, Canadian journal of physiology and pharmacology.
[47] P. Kudenchuk,et al. Prospective evaluation of amiodarone pulmonary toxicity. , 1984, Chest.